Overview
Lennox-Gastaut Syndrome (LGS) is a very rare form of epilepsy It typically begins in early childhood. LSG will cause you to experience different types of seizures, learning difficulties, and changes in the brain’s electrical activity. Since LGS can be difficult to treat, knowing the causes is essential. One important cause is changes, or mutations, in certain genes. LGS brings challenges for the individuals who suffer from this and their families. This article will explain which genetic mutations are linked to LGS, how they affect the brain, and why this knowledge matters.1
What is lennox-gastaut syndrome?
LGS will affect your brain and cause:
- Different types of seizures like muscle stiffening (tonic seizures), unexpected loss of muscle control (atonic seizures), and short staring spells (atypical absence seizures)
- Abnormal brain wave patterns seen on tests like EEG (electroencephalogram)
- Learning problems or intellectual disability
- Seizures that often do not get better with usual epilepsy medicines
LGS can happen for many reasons, it can come from brain injury or infections. But in many cases, changes in genes are involved.1
What are genes and genetic mutations?
Genes are parts of DNA that tell our body how to work and grow. Sometimes, genes change or mutate. Having a mutation can create problems with the mechanisms of the body. In LSG, certain gene mutations can affect how your brain cells communicate. The brain cells that are affected can lead to seizures. There are special tests to find gene mutations with people who have epilepsy. This can help with understanding the causes of seizures and finding a way to treat seizures.2
Important genes linked to lennox-gastaut syndrome
Many different genes have been found to cause or increase the risk of LGS. These genes mainly affect the brain cells ability to send signals correctly.
SCN1A gene
What it does: This gene makes a part of a sodium channel, which helps brain cells send electrical signals.3
How mutations affect: Changes in SCN1A can make these channels work poorly, causing brain cells to fire too much or too little.3
Effect on LGS: This can lead to severe seizures and learning difficulties.3
Additional info: Mutations in SCN1A are also common in other severe childhood epilepsies like Dravet syndrome.3
GABRB3 gene
What it does: This gene makes part of the GABA receptor. This helps calm brain activity.4
How mutations affect: Mutations can weaken this calming effect. This causes brain cells to become too active.4
Effect on LGS: This will make seizures more likely to happen and affect development.4
CHD2 gene
What it does: CHD2 helps with controlling how genes are turned on or off in brain cells.5
How mutations affect: Having this mutation can disrupt normal brain development.5
Effect on LGS: Patients will experience different types of seizures. The patients may also be sensitive to light.5
STXBP1 gene
What it does: This gene helps brain cells release chemicals that send messages between cells.6
How mutations affect: When mutated, this release process is disturbed.6
Effect on LGS: This can lead to seizures and having developmental problems.6
CDKL5 gene
What it does: CDKL5 is important for brain growth and forming connections between brain cells.7
How mutations affect: This mutation will bring early seizures and delays in development.7
Effect on LGS: Mainly affects girls, causing severe epilepsy and learning issues.7
Other genes that may be involved
Some less common genes linked to LGS are:
ALG13: Helps make proteins in cells.8
SLC2A1: Helps transport sugar (energy) into brain cells.9
KCNT1: Controls potassium channels, which affect brain signals.10
FOXG1: Important for early brain development. Mutations in these genes are rarer but still important in some cases of LGS.8
How are genetic mutations found?
Genetic testing helps to find mutations in children with LSG. The main tests include:
Whole-exome sequencing (WES): Looks at all the important parts of genes.
Chromosomal microarray: Detects larger changes in chromosomes
Gene panels: Tests for a group of genes linked to epilepsy.
When a doctor finds a mutation, it can confirm what caused the seizure. It can also help predict how the Illness might progress and doctors can choose medicine that works better for some mutations. Doctors can also give advice about having future children.11
Why knowing the genetics matters for treatment
At the moment, LSG is not easy to treat and usually doesn't respond well to medication. However, knowing the genetic cause can help with treatment. Some medicine might work better or worse depending on the mutation. For example, certain sodium channel blockers should not be taken for patients with the SCN1A mutations as it can make seizures worse. Having the genetic information can help with the research on new treatments such as gene therapy. Doctors can avoid trial and error in treatment and manage seizures better.12
Challenges in genetic understanding of LSG
Even with the advanced testing available, a lot of children with LSG don't have a known genetic mutation. This can happen because:
- There are undiscovered genes involved
- A combination of genes and other factors like a brain injury can cause LSG
- Mutations can also have different effects in different people13
What’s next? The future of genetic research in LGS
There is still ongoing research in finding new gene mutations linked to LGS. Scientists also study how gene changes will affect our brain function at a deeper level.
New technologies could allow:
- Having an earlier diagnosis before seizures start
- Creating a personal treatment that is based on a person's genetic makeup
- Correct mutations through gene therapy13
Summary
Genetic mutations play a big role in the development of Lennox-Gastaut Syndrome (LSG). Many different genes have been found to be linked to LSG. Each gene affects the brain function in different ways, SCN1A and KCNT1 influence how electrical signals are transmitted between brain cells. Others, like GABRB3 and CHD2, affect brain inhibition and gene regulation. These mutations affect normal brain development and contribute to seizures.
Genetic testing helps diagnose LSG, especially when the cause isn't known. Whole-exome sequencing and epilepsy gene panels techniques can help find known mutations and new ones. It's important to remember that not all patients with LSG will have an identifiable genetic mutation. Patients who do can benefit with personalised treatment and better care. Overall, genetics is a really important part of LSG care. Understanding the genetic bases helps with improving diagnosis, guiding therapy and furthering research in treatment that is effective.
References
- Jahngir MU, Ahmad MQ, Jahangir M. Lennox-gastaut syndrome: in a nutshell. Cureus [Internet]. [cited 2025 Jun 12];10(8):e3134. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207167/
- Zhang D, Liu X, Deng X. Genetic basis of pediatric epilepsy syndromes. Exp Ther Med [Internet]. 2017 May [cited 2025 Jun 12];13(5):2129–33. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443213/
- Ding J, Li X, Tian H, Wang L, Guo B, Wang Y, et al. Scn1a mutation—beyond dravet syndrome: a systematic review and narrative synthesis. Front Neurol [Internet]. 2021 Dec 24 [cited 2025 Jun 12];12:743726. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739186/
- Feng Y, Wei ZH, Liu C, Li GY, Qiao XZ, Gan YJ, et al. Genetic variations in GABA metabolism and epilepsy. Seizure: European Journal of Epilepsy [Internet]. 2022 Oct [cited 2025 Jun 12];101:22–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1059131122001601
- Feng W, Fang F, Wang X, Chen C, Lu J, Deng J. Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy. Pediatr Investig [Internet]. 2022 Apr 26 [cited 2025 Jun 12];6(2):93–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218986/
- Lammertse HCA, van Berkel AA, Iacomino M, Toonen RF, Striano P, Gambardella A, et al. Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission. Brain [Internet]. 2020 Feb [cited 2025 Jun 13];143(2):441–51. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009479/
- Mirzaa GM, Paciorkowski AR, Marsh ED, Berry-Kravis EM, Medne L, Grix A, et al. CDKL5 and ARX mutations in males with early-onset epilepsy. Pediatr Neurol [Internet]. 2013 May [cited 2025 Jun 13];48(5):367–77. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742321/
- De novo mutations in the classic epileptic encephalopathies. Nature [Internet]. 2013 Sep 12 [cited 2025 Jun 13];501(7466):217–21. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773011/
- Zhang D, Guo J, Lin Z, Yan H, Peng K, Fei L, et al. SLC2A1 variants cause late-onset epilepsy and the genetic-dependent stage feature. Acta Epileptologica [Internet]. 2024 Nov 7 [cited 2025 Jun 13];6(1):38. Available from: https://doi.org/10.1186/s42494-024-00177-0
- Cavirani B, Spagnoli C, Caraffi SG, Cavalli A, Cesaroni CA, Cutillo G, et al. Genetic epilepsies and developmental epileptic encephalopathies with early onset: a multicenter study. Int J Mol Sci [Internet]. 2024 Jan 19 [cited 2025 Jun 13];25(2):1248. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10816990/
- Qaiser F, Sadoway T, Yin Y, Zulfiqar Ali Q, Nguyen CM, Shum N, et al. Genome sequencing identifies rare tandem repeat expansions and copy number variants in Lennox-Gastaut syndrome. Brain Commun [Internet]. 2021;3(3):fcab207. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8491034/
- Zimmern V, Minassian B, Korff C. A review of targeted therapies for monogenic epilepsy syndromes. Front Neurol [Internet]. 2022 Feb 17 [cited 2025 Jun 13];13:829116. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891748/
- Cross JH, Auvin S, Falip M, Striano P, Arzimanoglou A. Expert opinion on the management of lennox–gastaut syndrome: treatment algorithms and practical considerations. Front Neurol [Internet]. 2017 Sep 29 [cited 2025 Jun 13];8. Available from: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2017.00505/full

